VASTox plc, of Oxford, UK, was granted a patent relating to its drug discovery program in Duchenne's muscular dystrophy...Vaxiion Therapeutics Inc., of San Diego, was issued U.S. Patent No

Dyax Corp., of Cambridge, Mass., was issued U.S. Patent No...GenVec Inc., of Gaithersburg, Md., was granted U.S. Patent No...IsoTis Inc., of Irvine, Calif., was awarded U.S. Patent No

ARC Pharmaceuticals Inc., of Vancouver, British Columbia, and the University of British Columbia received U.S. Patent No...Argos Therapeutics, of Durham, N.C., received U.S. Patent NO...Avicena Group Inc., of Palo Alto, Calif., received U.S. Patent No

Mirus Bio Corp., of Madison, Wis., received U.S. Patent No...NanoMed Pharmaceuticals Inc., of Kalamazoo, Mich., received U.S. Patent No...ScinoPharm Taiwan Ltd., of Tainan, Taiwan, received U.S. Patent No

Endocyte Inc., of West Lafayette, Ind., received U.S. Patent No...Epix Pharmaceuticals Inc., of Lexington, Mass., received U.S. Patent No...IsoTis SA, of Irvine, Calif., was awarded U.S. Patent No

SemBioSys Genetics Inc., of Calgary, Alberta, was granted U.S. Patent No...Targeted Genetics Corp., of Seattle, was issued U.S. Patent No...Vical Inc., of San Diego, was issued U.S. Patent No

Isotechnika Inc., of Edmonton, Alberta, received U.S. Patent No...Inc., of Bothell, Wash., received U.S. Patent No...Oragenics Inc., of Alachua, Fla., received U.S. Patent No

4SC AG, of Martinsried, Germany, received U.S. Patent No...Alnylam Pharmaceuticals Inc., of Cambridge, Mass., was issued U.S. Patent No...AlphaVax Inc., of Research Triangle Park, N.C., was issued U.S. Patent No

Stem Cell Therapeutics Corp., of Calgary, Alberta, received U.S. Patent No...The company also received U.S. Patent No...SuperGen Inc., of Dublin, Calif., received U.S. Patent No

Neuren Pharmaceuticals Ltd., of Sydney, Australia, was granted U.S. Patent No...OxiGene Inc., of Waltham, Mass., was issued U.S. Patent No...Phylonix Pharmaceuticals Inc., of Cambridge, Mass., received U.S. Patent No

EntreMed Inc., of Rockville, Md., was issued U.S. Patent No...GenoMed Inc., of St. Louis, received U.S. Patent No...Introgen Therapeutics Inc., of Austin, Texas, received U.S. Patent No

Morphotek Inc., of Exton, Pa., was issued U.S. Patent No...Provectus Pharmaceuticals Inc., of Knoxville, Tenn., received U.S. Patent No...Sirna Therapeutics Inc., of San Francisco, received U.S. Patent No

Androclus Therapeutics Inc., of San Diego, received U.S. Patent No...Cel-Sci Corp., of Vienna, Va., received U.S. Patent No...MannKind Corp., of Valencia, Calif., received U.S. Patent No

The patent would cover immunotherapy approaches directed against the 5T4 tumor antigen...Source MDx, of Boulder, Colo., was issued U.S. Patent No

Nanosphere Inc., of Northbrook, Ill., received U.S. Patent No...NovaDel Pharma Inc., of Flemington, N.J., received U.S. Patent Nos...OncoMed Pharmaceuticals Inc., of Mountain View, Calif., was granted U.S. Patent No

MediQuest Therapeutics Inc., of Bothell, Wash., was issued U.S. Patent No...Nanogen Inc., of San Diego, received U.S. Patent No...Nanogen's subsidiary, Epoch Biosciences Inc., of Bothell, Wash., recently received U.S. Patent No

Specifically, the patent refers to the simultaneous removal of the 3'-blocks and nucleotide labels during the SBS process, providing for shorter reaction times and greater system throughput...Source MDx, of Boulder, Colo., received U.S. Patent No

Nanogen Inc., of San Diego, received U.S. Patent No...Senomyx Inc., of La Jolla, Calif., received U.S. Patent No

Pro-Pharmaceuticals Inc., of Newton, Mass., received U.S. Patent No...PSivida Ltd., of Perth, Australia, received U.S. Patent No...Semafore Pharmaceuticals Inc., of Indianapolis, received U.S. Patent No